TFCP2_CHICK
ID TFCP2_CHICK Reviewed; 496 AA.
AC Q7T2U9;
DT 21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2003, sequence version 1.
DT 03-AUG-2022, entry version 99.
DE RecName: Full=Transcription factor CP2;
GN Name=TFCP2;
OS Gallus gallus (Chicken).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC Phasianinae; Gallus.
OX NCBI_TaxID=9031;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX PubMed=15107494; DOI=10.1093/nar/gkh545;
RA Acloque H., Mey A., Birot A.-M., Gruffat H., Pain B., Samarut J.;
RT "Transcription factor cCP2 controls gene expression in chicken embryonic
RT stem cells.";
RL Nucleic Acids Res. 32:2259-2271(2004).
CC -!- FUNCTION: Binds the B-response element 5'-CAAGTCCAGGCAAGT-3' of the
CC ENS1/ERNI promoter. May be the major transcription activator thus being
CC essential for its expression. {ECO:0000269|PubMed:15107494}.
CC -!- SUBUNIT: Component of the SSP (stage selector protein) complex, which
CC appears to be a heteromer of TFCP2 and 2 copies of NFE4. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Expressed in the epiblast at the pre-primitive
CC streak stage. At the primitive streak stage, expressed in the extending
CC primitive streak and in the prospective neural plate. At stages 7 and
CC 8, expressed in the neural folds, somites and in the regressing
CC primitive streak. At stage 12, ubiquitously expressed in the whole
CC embryo. {ECO:0000269|PubMed:15107494}.
CC -!- SIMILARITY: Belongs to the grh/CP2 family. CP2 subfamily.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AY298725; AAP56347.1; -; mRNA.
DR RefSeq; NP_989715.1; NM_204384.1.
DR AlphaFoldDB; Q7T2U9; -.
DR SMR; Q7T2U9; -.
DR STRING; 9031.ENSGALP00000003492; -.
DR PaxDb; Q7T2U9; -.
DR GeneID; 378900; -.
DR KEGG; gga:378900; -.
DR CTD; 7024; -.
DR VEuPathDB; HostDB:geneid_378900; -.
DR eggNOG; KOG4091; Eukaryota.
DR HOGENOM; CLU_015127_2_0_1; -.
DR InParanoid; Q7T2U9; -.
DR PRO; PR:Q7T2U9; -.
DR Proteomes; UP000000539; Unplaced.
DR GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR GO; GO:0042789; P:mRNA transcription by RNA polymerase II; IEA:Ensembl.
DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR Gene3D; 1.10.150.50; -; 1.
DR InterPro; IPR007604; CP2.
DR InterPro; IPR013761; SAM/pointed_sf.
DR InterPro; IPR041418; SAM_3.
DR Pfam; PF04516; CP2; 1.
DR Pfam; PF18016; SAM_3; 1.
DR SUPFAM; SSF47769; SSF47769; 1.
DR PROSITE; PS51968; GRH_CP2_DB; 1.
PE 2: Evidence at transcript level;
KW DNA-binding; Nucleus; Reference proteome; Transcription;
KW Transcription regulation.
FT CHAIN 1..496
FT /note="Transcription factor CP2"
FT /id="PRO_0000228003"
FT DOMAIN 61..300
FT /note="Grh/CP2 DB"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01313"
FT REGION 133..386
FT /note="DNA-binding"
FT /evidence="ECO:0000250"
FT REGION 238..268
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 296..327
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 239..267
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 496 AA; 56473 MW; 94C451AF30BD249B CRC64;
MAWALKLPLA DEVIESGLVQ DFDASLSGIG QELGAGAYSM SDVLALPIFK QEESSLPPEN
ENKILPFQYV LCAATSPAVK LHDETLTYLN QGQSYEIRML DNRKIGELPE INGKLVKSIF
RVVFHDRRLQ YTEHQQLEGW RWNRPGDRIL DIDIPMSVGI IDPRANPTQL NTVEFLWDPS
KRTSVFIQVH CISTEFTMRK HGGEKGVPFR VQIDTFKENE NGEYTEHLHS ASCQIKVFKP
KGADRKQKTD REKMEKRTPH EKEKYQPSYE TTILTECSPW PEITYVNNAP SPGFNSSHSS
FSIGEGNGSP NHQPEPPPPI ADNLLPTSTP QEAQQWLHRN RFSTFSRLFR NFSGADLLKL
TREDVIQICG PADGIRLFNA LKGRMVRPRL TIYVCQESQQ LQELQQKHED GDAVTSTFFV
YHAIYLEELT AVELTEKLAQ LFSISSQQIS QIYKQGPTGI HVLISDEMIQ NFQDESCFVL
DTMKAETNDS YHIILK